Impact on urinary oxalate levels with use of ezetimibe

BACKGROUND: Calcium oxalate stones are the most common cause of nephrolithiasis in the United States. Smaller studies of <15 patients investigating ezetimibe, a selective cholesterol absorption inhibitor, have suggested increased urine oxalate levels with use of the drug. We attempt to better def...

Descripción completa

Detalles Bibliográficos
Autores principales: Trautman, Christopher L., Van Cleve, Margaret, Sullivan, Emily A., Ball, Colleen T., Cochuyt, Jordan J., Porter, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029507/
https://www.ncbi.nlm.nih.gov/pubmed/33855221
http://dx.doi.org/10.1002/edm2.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029507/
https://www.ncbi.nlm.nih.gov/pubmed/33855221
http://dx.doi.org/10.1002/edm2.221

Ejemplares similares